Post-approval studies (Phase 4)WithdrawnNCT01822951
What this trial is testing
Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Who this might be right for
Alzheimer Disease
Ever Neuro Pharma GmbH